ClearPoint Neuro Inc (CLPT)
6.07
-0.06
(-0.98%)
USD |
NASDAQ |
May 21, 16:00
6.06
-0.01
(-0.16%)
After-Hours: 20:00
ClearPoint Neuro Enterprise Value: 141.05M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 21, 2024 | 141.05M |
May 20, 2024 | 142.70M |
May 17, 2024 | 144.62M |
May 16, 2024 | 150.10M |
May 15, 2024 | 150.10M |
May 14, 2024 | 139.41M |
May 13, 2024 | 135.02M |
May 10, 2024 | 135.29M |
May 09, 2024 | 142.15M |
May 08, 2024 | 138.86M |
May 07, 2024 | 136.12M |
May 06, 2024 | 137.49M |
May 03, 2024 | 135.57M |
May 02, 2024 | 125.97M |
May 01, 2024 | 123.23M |
April 30, 2024 | 123.48M |
April 29, 2024 | 120.74M |
April 26, 2024 | 118.82M |
April 25, 2024 | 120.19M |
April 24, 2024 | 120.47M |
April 23, 2024 | 125.40M |
April 22, 2024 | 125.67M |
April 19, 2024 | 120.74M |
April 18, 2024 | 122.38M |
April 17, 2024 | 126.22M |
Date | Value |
---|---|
April 16, 2024 | 127.59M |
April 15, 2024 | 128.42M |
April 12, 2024 | 133.90M |
April 11, 2024 | 144.59M |
April 10, 2024 | 143.50M |
April 09, 2024 | 149.53M |
April 08, 2024 | 146.79M |
April 05, 2024 | 150.90M |
April 04, 2024 | 149.53M |
April 03, 2024 | 155.56M |
April 02, 2024 | 151.45M |
April 01, 2024 | 159.12M |
March 31, 2024 | 161.04M |
March 28, 2024 | 170.88M |
March 27, 2024 | 168.72M |
March 26, 2024 | 163.84M |
March 25, 2024 | 169.26M |
March 22, 2024 | 164.66M |
March 21, 2024 | 171.42M |
March 20, 2024 | 176.30M |
March 19, 2024 | 175.75M |
March 18, 2024 | 178.19M |
March 15, 2024 | 179.69M |
March 14, 2024 | 181.31M |
March 13, 2024 | 180.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
35.47M
Minimum
Jun 25 2019
504.59M
Maximum
Feb 16 2021
181.98M
Average
162.94M
Median
Enterprise Value Benchmarks
icad Inc | 22.98M |
Perspective Therapeutics Inc | 811.05M |
Xtant Medical Holdings Inc | 120.67M |
Asensus Surgical Inc | 59.55M |
Catheter Precision Inc | 2.942M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -4.146M |
Revenue (Quarterly) | 7.639M |
Total Expenses (Quarterly) | 11.87M |
EPS Diluted (Quarterly) | -0.16 |
Gross Profit Margin (Quarterly) | 59.24% |
Profit Margin (Quarterly) | -54.27% |
Earnings Yield | -13.84% |
Normalized Earnings Yield | -13.84 |